NRF2 upregulation is a well-established mechanism through which many human cancers have increased aggression and malignancy through tumour proliferation and survival via therapeutic resistance [199] and immune evasion; such cancers are often characterised as “NRF2-addicted” [200,201]. Here, NFE2L2 is linked to cancer.